Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase NA 3Phase 4 3Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Keratosis, Actinic 3Skin Diseases 1Connective Tissue Diseases 1Carcinoma, Basal Cell 1Bowen's Disease 1

Interventions

Imiquimod 11Aminolevulinic Acid 8Diclofenac 63-ingenyl angelate 6Fluorouracil 5Cryotherapy 5tirbanibulin 4methyl 5-aminolevulinate 3Photochemotherapy 3Ointments 2Gels 2Cryosurgery 2bacitracin, polymyxin B drug combination 1Solutions 1Radiotherapy 1Prilocaine 1Petrolatum 1Menthol 1Lidocaine 1Curettage 1Biafine 1Bacitracin 1BF-200 ALA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Keratosis, Actinic × methyl 5-aminolevulinate × Clear all
NCT03511326 2021-02-18

SESAME 2

Galderma R&D

Phase 4 Completed
50 enrolled 9 charts
Dermatologic

Keratosis, Actinic

NCT02464709 2019-08-28

Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)

Joint Authority for Päijät-Häme Social and Health Care

Phase 4 Completed
72 enrolled
Dermatologic

Keratosis, Actinic

NCT01538901 2017-09-12

AKtransplant

Medical University of Vienna

Phase 4 Terminated
10 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡